Mention it at your next routine visit so it can be interpreted in context
Never miss out on a new bog, special or event
Collectively, these mechanisms explain how GLP-1 receptor agonists exert their cardioprotective effects, with implications for managing cardiovascular risk across multiple patient populations
Clinical studies have produced inconsistent results for outcomes such as physical performance, metabolic health, and other measures associated with healthy aging
doi: 10.3389/fpsyt.2025.1569826 Edited by Sandra Moreno, Roma Tre University, Italy Reviewed by Poonam Chanderlal Sharma, University of Mississippi Medical Center, United States Ashish Patil, Roche, United States Updates Copyright 2025 Han, Almeida, Anand, Salloum, Kanaan, Gadad and Daher
evidence for absorption, dose equivalence, and outcomes is limited, and the FDA has warned about dosing errors and quality concerns with compounded GLP1 products